Multiple sclerosis (MS) is an incurable, chronic inflammatory disease of the central nervous system, which destroys the medulla substance.
The present invention relates to the use of R-Flurbiprofen (Tarenflurbil) for the treatment of MS.
Further Information: PDF
INNOVECTIS Gesellschaft für Innovations-Dienstleistungen mbH
Phone: +49 (0)69/2561632-0
Contact
Dr. Otmar Schöller
